A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18927313

Clin. Cancer Res. 2008 Oct 15 14 20 6697-703

Download in:

View as

Triples

General Info

PMID
18927313